Jacqueline H.

Jacqueline H. has extensive experience in the pharmaceutical industry, particularly in medical affairs and clinical development within oncology and hematology. Starting as a Medical Manager at Aventis from 2002 to 2004, Jacqueline developed clinical strategies in China for the oncology portfolio. At Novartis from 2004 to 2008, Jacqueline held roles such as Senior Medical Advisor for the Asia-Pacific region and Clinical Program Leader, where responsibilities included leading regional medical affairs and overseeing global oncology/hematology programs. From 2013 to 2018, as Medical Development Director at Amgen, Jacqueline built a medical development team, managed portfolio activities across multiple therapeutic areas, and contributed to both regional and global strategy as the Global Development Lead, facilitating advancement from early to late-stage clinical trials.